Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Freedoms Study Group, Raymond Hupperts

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)420-428
JournalLancet Neurology
Volume11
Issue number5
DOIs
Publication statusPublished - May 2012

Cite this